Regionalized Management of Medicine

1. Auflage 2022
ISBN: 978-981-16-7892-9
Verlag: Springer Nature Singapore

Buch, Englisch, Band 17, 226 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 567 g

Reihe: Translational Bioinformatics

The Book mainly focuses on various aspects of regionalized management of medicine, related with updates of new biotechnology, application of therapeutic strategy, and understanding of disease-associated molecular mechanisms. The book also discusses how medical informatics, systems analysis, database sharing, and artificial intelligent can be applied for improving the quality of hospital managements, disease therapies, regional collaborations, and medical services.

This book serves as a professional reference book to clinicians and experts who are interested in medical informatics and artificial intelligence for diseases therapies and therapeutic strategy, better systems analysis and database sharing, and more efficient regional collaborations and medical services.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Shen, Hui

Wang, Xiangdong

Zeng, Yiming

Li, Li

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Biomedizin, Medizinische Forschung, Klinische Studien
• Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie Verhaltenstherapie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizinische Mathematik & Informatik

Inhaltsverzeichnis

Introduction: The importance of regionalized management of medicine.- Alcohol use disorders.- Public-private partnerships management in health care: The Portuguese experience.- Management of Clinical Precision Medicine.- Artificial Intelligence in medical management.- Advanced Demand Forecasting and Inventory Management Methods in Hospital Pharmacy.- Clinical Application of Cell-Based Therapies Opportunities and Challenges.- Management of Next-Generation Sequencing (NGS) in Precision Medicine.- Exploration on the Reform of County Medical Integration .- The Regionalization of Medical Management: The Practice and Exploration of Established Fudan-Minhang Medical Alliance.- Bed-occupancy management and hospital planning: a handbook.- Management of severe childhood pneumonia in low resource setting.- The role of mitochondrial-targeted antioxidant, MitoQ, in neurodegenerative disease.- Progression of mitochondria research for clinical potentials.- DNA methylation in pulmonary inflammatory diseases.- Synthetic lethality and lung cancer.

Über Autor(innen)

Hui Shen, MD, Dean of Jinshan Hospital Affiliated to Fudan University, President of Yangtze River Delta Integration Gene Testing Alliance, Shanghai, China. His research focus on studying hospital human resource management, cultural construction, and hospital operation process. He is also the standing director of Shanghai Hospital Association, Vice President of Shanghai Health Education Association (President of Hospital Branch).

Yi-Ming Zeng, MD, Professor and Dean of the Second Hospital of Fujian Medical University, member of State Expert Council for Special Allowance, and Director of Sleep Medicine Key Laboratory of Fujian Province. He achieved the Outstanding Contribution of Middle-aged Expert of National Health and Family Planning Commission of the People's Republic of China (NHFPC). His main research is focused on clinical, interventional pulmonology, sleep-breathing disorders, and noninvasive mechanical ventilation. He is the author of more than 150scientific publications.

Li Li, Director of Department of Science Research and Discipline Construction, Henan Provincial people's Hospital. She is Member of clinical research group of Chinese Medical Association’s Scientific Research Management Branch, Standing Committee member of Chinese Medical Association’s Henan Research and Management Branch, Vice-chairman of Henan Discipline Management Branch of Chinese Hospital Management Society. She has engaged in the management of medical scientific research for 30 years and her main research is focused on health management scientific research big data, laboratory biosafety, medical ethics. She published more than 20 scientific papers.

Xiangdong Wang, MD, PhD, is a Distinguished Professor of Medicine at Fudan University, Director of Shanghai Institute of Clinical Bioinformatics, Director of Fudan University Center of Clinical Bioinformatics, Director of Shanghai Shanghai Engineering Research Center for AI Technology of Cardiopulmonary Diseases, Deputy Director of Shanghai Respiratory Research Institute, Executive Director of Clinical Science Institute of Fudan University Zhongshan Hospital, and visiting professor of King’s College of London. He serves as the President of Chinese Society of Gene Technology, Deputy President of National Committee of Clinical Precision Medicine, Chinese Medical Doctor Association. His main research is focused on single cell sequencing, clinical bioinformatics, disease-specific biomarkers, lung chronic diseases, cancer immunology, and molecular & cellular therapies. He is the author of more than 300 scientific publications with the impact factor about 1100, citation number about 9923, h-index 51, and i10-index 256.